Australia markets closed

Innoviva Inc (HVE.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
17.30-0.40 (-2.26%)
At close: 08:08AM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
330,496
310,463
331,339
391,866
336,794
Cost of revenue
42,755
42,640
13,793
0
0
Gross profit
287,741
267,823
317,546
391,866
336,794
Operating expenses
Research development
12,783
33,922
41,432
576
1,788
Selling general and administrative
113,100
98,232
63,538
16,187
13,883
Total operating expenses
151,784
153,938
110,551
16,763
15,671
Operating income or loss
135,957
113,885
206,995
375,103
321,123
Interest expense
22,001
19,157
15,789
19,070
18,331
Total other income/expenses net
22,269
83,552
89,374
87,404
49,929
Income before tax
152,998
194,098
286,949
445,276
354,245
Income tax expense
7,574
14,376
66,687
76,439
60,431
Income from continuing operations
145,424
179,722
220,262
368,837
293,814
Net income
145,424
179,722
213,921
265,854
224,402
Net income available to common shareholders
145,424
179,722
213,921
265,854
224,402
Basic EPS
0.81
2.75
3.07
3.24
2.21
Diluted EPS
0.75
2.20
2.37
2.87
2.02
Basic average shares
66,926
65,435
69,644
82,062
101,320
Diluted average shares
89,572
86,876
95,249
94,311
113,554